Lilly expands its cancer drug work with bet on dual-acting antibodies
Bio Pharma Dive
JANUARY 19, 2021
An alliance with Merus, a Dutch biotech, continues Lilly's push to revitalize its oncology research under the leadership of former Loxo Oncology executives.
Let's personalize your content